Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY. Broome DT, Mehdi A, Chase C, de Freitas MF, et al. Diabetes Care 2024;47:e65-e66.

Read + Share

Amedeo Smart

Independent Medical Education

Broome DT, Mehdi A, Chase C, de Freitas MF, et al. Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY. Diabetes Care 2024;47:e65-e66.
PMID: 39008714